Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 7—July 2023
Dispatch

Candida vulturna Outbreak Caused by Cluster of Multidrug-Resistant Strains, China

Han Du1, Jian Bing1, Xiaohong Xu1, Qiushi Zheng, Tianren Hu, Yajuan Hao, Shuping Li, Clarissa J. Nobile, Ping Zhan2Comments to Author , and Guanghua Huang2Comments to Author 
Author affiliations: Huashan Hospital, Fudan University, Shanghai, China (H. Du, J. Bing, Q. Zheng, T. Hu, G. Huang); Sinopharm Tongmei General Hospital, Datong, China (X. Xu, Y. Hao, S. Li); University of California, Merced, California, USA (C.J. Nobile); Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, China (P. Zhan)

Main Article

Table

Susceptibility profiles of Candida vulturna isolates from 19 infected patients to 9 antifungal drugs, Shanxi Province, China, January 1, 2019–October 26, 2022*

Patient no. Strain ID FLC VOC ITC POC CAS MFG AFG 5-FC AMB
C1 CVDH01 32 32 64 64 0.125 0.5 0.125 0.06 4
C2 CVDH02 128 32 32 16 0.06 0.5 0.125 0.06 4
C3 CVDH03 64 32 32 32 0.06 0.25 0.125 0.06 4
C4 CVDH04 128 32 16 16 0.125 0.5 0.06 0.06 4
C5 CVDH05 128 32 32 32 0.125 0.5 0.06 0.06 4
C6 CVDH06 128 32 32 32 0.125 0.5 0.125 0.06 4
C7 CVDH07 256 64 64 64 0.06 0.25 0.125 0.06 4
C8 CVDH08 128 32 32 32 0.25 0.5 0.125 0.06 4
C9 CVDH09 128 32 32 64 0.06 0.25 0.25 0.06 4
C10 CVDH10 128 32 16 16 0.125 0.5 0.125 0.06 4
C11 CVDH11 256 64 64 64 0.125 0.5 0.125 0.06 4
C12 CVDH12 128 32 64 64 0.06 0.25 0.125 0.06 4
C13 CVDH13 64 32 32 32 0.06 0.25 0.125 0.06 4
C14 CVDH14 64 16 32 32 0.03 0.5 0.03 0.06 4
C15 CVDH15 128 64 32 16 0.06 0.25 0.125 0.06 4
C16 CVDH16 128 32 64 32 0.125 0.5 0.125 0.06 4
C17 CVDH17 64 32 32 32 0.06 0.5 0.06 0.06 4
C18 CVDH18 64 8 32 32 0.06 0.5 0.06 0.06 4
C19 CVDH19 64 32 32 32 0.06 0.5 0.06 0.06 4

*MIC assays were performed according to Clinical and Laboratory Standards Institute microdilution guidelines. Bold text indicates antifungal resistance (based on the breakpoints for C. albicans). AFG, anidulafungin; AMB, amphotericin B; CAS, caspofungin; FLC, fluconazole; ITC, itraconazole; MFG, micafungin; POC, posaconazole; VOC, voriconazole; 5-FC, flucytosine.

Main Article

1These first authors contributed equally to this article.

2These senior authors contributed equally to this article.

Page created: May 22, 2023
Page updated: June 21, 2023
Page reviewed: June 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external